Hemoglobin SC Disease: Clinical Trials

6 trials for Hemoglobin SC Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 not yet recruiting, 1 unknown. 6 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 4, Not yet recruiting 1, Unknown 1
Phase 21Completed 1

Follow Hemoglobin SC Disease: new trials by email Literature Review of Hemoglobin SC Disease trials Research Report on Hemoglobin SC Disease

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Buprenorphine for the Management of Pain in Children With Sickle Cell Disease
Buprenorphine Buccal Film [Belbuca] - Sickle Cell Disease (SCD), Sickle Cell Disease Vaso-occlusive Crisis
Phase 1Not yet recruitingNatasha Archer252026-10-012026-09-02
Pharmacokinetics of Oral Hydroxyurea Solution
Oral Hydroxyurea (100 mg/mL) Solution - Sickle Cell Disease, Sickle-Cell; Hemoglobin Disease, Thalassemia
Phase 1 / Phase 2CompletedNova Laboratories Limited332019-01-032024-10-28
A Study of IMR-687 in Healthy Adult Volunteers
IMR-687, Placebo Oral Capsule - Sickle Cell Disease, Sickle-Cell; Hb-SC
Phase 1CompletedCardurion Pharmaceuticals, Inc.662016-10-182025-05-15
Safety Study of MP4CO in Adult Sickle Cell Patients
MP4CO, Sodium chloride solution - Anemia, Sickle Cell, Sickle Cell Anemia
Phase 1CompletedSangart322012-01-012013-08-19
Far Infrared Radiation for Sickle Cell Pain Management
Far Infrared Radiation (5μm to 20μm wavelength) - Anemia, Sickle Cell
Phase 1UnknownGAAD Medical Research Institute Inc.102008-01-012009-01-05
A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders
Recombinant-methionyl human stem cell factor - Hemoglobin SC Disease, Sickle Cell Anemia
Phase 1CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)502000-03-012008-03-04

Narrower conditions

Anemia, Sickle Cell (6)  ·  Vaso-Occlusive Crises (3)  ·  Thalassemia (2)  ·  Acute Pain (1)  ·  Hemoglobin C Disease (1)  ·  Hemoglobinopathies (1)  ·  Sickle Cell Trait (1)  ·  beta-Thalassemia (1)

Broader conditions

Anemia (6)  ·  Anemia, Hemolytic (6)  ·  Anemia, Hemolytic, Congenital (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Genetic Diseases, Inborn (6)  ·  Hematologic Diseases (6)  ·  Hemic and Lymphatic Diseases (6)  ·  Hemoglobinopathies (5)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Thalassemia (1)

Interventions

Buprenorphine (1)  ·  Hydroxyurea (1)  ·  PEGylated carboxyhemoglobin bovine (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Solutions (1)  ·  ancestim (1)  ·  microcrystalline cellulose (1)

Sponsors

Cardurion Pharmaceuticals, Inc. (1)  ·  GAAD Medical Research Institute Inc. (1)  ·  Natasha Archer (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Nova Laboratories Limited (1)  ·  Sangart (1)

Countries

United States (3)  ·  Jamaica (2)  ·  United Kingdom (2)  ·  Canada (1)  ·  France (1)  ·  Lebanon (1)

Top investigators

Angela E Rankine- Mullings, MD (1)  ·  Ken Nedd, M.D. (1)  ·  Kwasi Donyina, Ph.D. (1)  ·  Natasha Archer, MD (1)  ·  Regulatory Operations (1)  ·  Tania Small, MD (1)

NIH funding

2017 (1)